Trials / Conditions / Levodopa-induced Dyskinesia

Levodopa-induced Dyskinesia

6 registered clinical trials studyying Levodopa-induced Dyskinesia.

Status	Trial	Sponsor	Phase
Completed	A Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's D NCT05435729	Sumitomo Pharma Co., Ltd.	Phase 1
Unknown	Double Randomized and Placebo Controlled Trail of Tianqi Pingchan Granule to Prevent Levodopa-Induced Dyskines NCT04173845	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	N/A
Unknown	Phase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's NCT06021756	University of Arizona	Phase 1
Completed	Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study) NCT01397422	Adamas Pharmaceuticals, Inc.	Phase 2 / Phase 3
Terminated	Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia NCT00607451	Neurim Pharmaceuticals Ltd.	Phase 1 / Phase 2
Unknown	Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease NCT00291733	1st Hospital of Social Security Services	Phase 2